Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Sales of vaccines for shingles, human papillomavirus and bacterial pneumonia slowed considerably over the first three months of the year, according to financial results disclosed this week by Merck & Co. and GlaxoSmithKline.